TLR4 and breast cancer: In particular, EECP and CAPE inhibited TLR-4 signaling pathway molecules such as TLR-4, MyD88, IRAK4, TRIF, and NF-κBp65, which might be one of the underlying mechanisms of the inhibition of breast cancer cells proliferation and survival.